Hypoxia improvement group (n = 209)

Hypoxia not improved group (n = 40)

P

Sex, number of cases (%)

0.031

male

137 (65.6)

19 (47.5)

female

72 (34.4)

21 (52.5)

Age, number of cases (%)

<0.001

Less than 3 years old

46 (22.0)

4 (10.0)

3 - 6 years old

78 (37.3)

9 (22.5)

6 - 12 years old

60 (28.7)

8 (20.0)

12 - 18 years old

25 (12.0)

19 (47.5)

Body weight (kg), mean ± SD

19.19 ± 11.06

25.56 ± 11.45

0.001

Hemoglobin value before blood transfusion (g/L), mean ± standard deviation

53.80 ± 9.56

51.40 ± 9.20

0.145

Hemoglobin value after infusion (g/L), mean ± standard deviation

79.03 ± 16.03

64.9 ± 16.09

<0.001

Malignant disease, cases (%)

0.51

Yes

135 (64.6)

28 (70.0)

No

74 (35.4)

12 (30.0)

Type of red blood cell suspension infused, number of cases (%)

0.356

Red blood cell suspension

188 (90.0)

34 (85.0)

Wash red blood cell suspension

21 (10.0)

6 (15.0)

Whether there is fever before infusion, number of cases (%)

0.261

Yes

41 (19.6)

11 (27.5)

No

168 (80.4)

29 (72.5)

Whether blood transfusion is timely, number of cases (%)

0.009

timely

181 (86.6)

28 (70.0)

delay

28 (13.4)

12 (30.0)

No fever before blood transfusion, fever after blood transfusion, cases (%)

0.011

Yes

25 (14.9)

10 (34.5)

No

143 (85.1)

19 (65.5)